Bristol Myers Squibb: A Cautious Optimism Amidst Looming Headwinds

Regeneron's Remarkable Resurgence: Charting the Course of a Biotech Comeback

A Shifting Landscape: Trump, Cannabis, and the Power of the Purse

The 'Skinny Label' Showdown: How a Supreme Court Case Could Redefine Generics and Drug Prices

ASH 2025: Glimmers of Hope and Big Strides in Blood Disorders

Bengaluru Gears Up for Vital New Drug Testing Lab, Promising Faster Results and Safer Medicines

A Sweeping Review: CDC's ACIP Panel Takes a Hard Look at the Entire Childhood Vaccine Schedule

Roche's Enduring Appeal: Navigating Growth Amidst Valuation Concerns

A New Era for Public Health: CDC Panel Greenlights Universal Hepatitis B Vaccination

Unpacking Pharma's Future: Costs, Generics, and the Tug-of-War for Access

A New Chapter for Multiple Sclerosis Treatment: Lupin's Landmark USFDA Approval

The Buzz from the Street: Top Stocks Drawing Analyst Attention This Thursday

The Anticipation Builds: ASH 2025 and the Evolving Landscape of Blood Cancer Therapies

The FDA's Bold New Vision: Could One Clinical Trial Be Enough for Drug Approval?

A Glimmer of Hope for Hair Loss Sufferers: Cosmo Pharma's Breezula Delivers in Landmark Trial

A Notable Shift: Dr. Theresa Michele Steps Down from FDA's Nonprescription Drug Leadership

Sai Parenterals Makes a Bold Global Move, Acquires Majority Stake in Australia's Noumed

The Fight for Affordable Medicine: Hospitals Take On 340B Program Changes

A New Prescription for Prosperity: US & UK Seal Zero-Tariff Pharma Deal

A New Dawn for Skin Cancer Patients: Citius Oncology Launches Lymphir in the US

RBC Puts the Brakes on PTC Therapeutics: Is Sephiance's Promise Already Priced In?

Europe's Quiet Ascent: How Old-World Giants Are Reshaping Global Stock Leadership

Navigating Medicare's Evolving Landscape: AARP's Crucial Insights for Your Future

The GLP-1 Revolution: A Wake-Up Call for Obesity Prevention

The Hidden Dangers of Too Much 'Good': Australia's Vitamin B6 Reckoning

Eli Lilly's Short-Term Horizon: A Look at Market Expectations

Navigating the Market: Expert Takes on Delta, Amex, Pfizer, and Harmony Gold

Beyond the Hype: Why Sanofi's CEO Says AI Won't 'Cure' Cancer

A New Era for Drug Prices: How Medicare's Negotiation Power is Reshaping Healthcare

Urogen Pharma: Unpacking the Quiet Potential of ZUSDURI in Bladder Cancer

Novartis Shares Soar as FDA Gives Landmark Nod to Zolgensma Gene Therapy for Teens and Adults

A New Era for Biotech: Landmark Commission Calls for Radical Research Funding Overhaul

Novo Nordisk's Alzheimer's Trial Setback: A Closer Look

Another Heartbreak in the Alzheimer's Fight: J&J's Posdinemab Stumbles

Novo Nordisk's Alzheimer's Ambition Dashed: Semaglutide Trial Fails, Stock Plummets

Forging Futures: Modi and Ramaphosa Boost Bilateral Bonds

The Shifting Sands of Pharma and Biotech: Navigating a Dynamic Job Market

When Leadership Takes the Reins: Unpacking the FDA's Unusual Priority Voucher Vote

A Glimmer of Hope? Novo Nordisk's GLP-1 Drug and the Alzheimer's Enigma